Bartel S - Search Results

1

A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma.

Burt BM, Richards WG, Lee HS, Bartel S, Dasilva MC, Gill RR, Jaklitsch MT, Johnson BE, Swanson SJ, Bueno R, Sugarbaker DJ. Burt BM, et al. Among authors: bartel s. J Thorac Oncol. 2018 Sep;13(9):1400-1409. doi: 10.1016/j.jtho.2018.04.032. Epub 2018 May 9. J Thorac Oncol. 2018. PMID: 29753120 Free article. Clinical Trial.

2

A phase I and pharmacokinetic study of a new camptothecin derivative, 9-aminocamptothecin.

Rubin E, Wood V, Bharti A, Trites D, Lynch C, Hurwitz S, Bartel S, Levy S, Rosowsky A, Toppmeyer D, et al. Rubin E, et al. Among authors: bartel s. Clin Cancer Res. 1995 Mar;1(3):269-76. Clin Cancer Res. 1995. PMID: 9815982 Clinical Trial.

3

Medication safety in the ambulatory chemotherapy setting.

Gandhi TK, Bartel SB, Shulman LN, Verrier D, Burdick E, Cleary A, Rothschild JM, Leape LL, Bates DW. Gandhi TK, et al. Cancer. 2005 Dec 1;104(11):2477-83. doi: 10.1002/cncr.21442. Cancer. 2005. PMID: 16245353 Free article.

4

Denosumab in hypercalcemia of malignancy: a case series.

Dietzek A, Connelly K, Cotugno M, Bartel S, McDonnell AM. Dietzek A, et al. Among authors: bartel s. J Oncol Pharm Pract. 2015 Apr;21(2):143-7. doi: 10.1177/1078155213518361. Epub 2014 Jan 10. J Oncol Pharm Pract. 2015. PMID: 24415364

5

Medication errors involving oral chemotherapy.

Weingart SN, Toro J, Spencer J, Duncombe D, Gross A, Bartel S, Miransky J, Partridge A, Shulman LN, Connor M. Weingart SN, et al. Among authors: bartel s. Cancer. 2010 May 15;116(10):2455-64. doi: 10.1002/cncr.25027. Cancer. 2010. PMID: 20225328 Free article.

6

Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors.

McCollum AD, Kulke MH, Ryan DP, Clark JW, Shulman LN, Mayer RJ, Bartel S, Fuchs CS. McCollum AD, et al. Among authors: bartel s. Am J Clin Oncol. 2004 Oct;27(5):485-8. doi: 10.1097/01.coc.0000135343.06038.eb. Am J Clin Oncol. 2004. PMID: 15596916

7

Variation in administration of cyclophosphamide and mesna in the treatment of childhood malignancies.

Sievers TD, Lagan MA, Bartel SB, Rasco C, Blanding PJ. Sievers TD, et al. Among authors: bartel sb. J Pediatr Oncol Nurs. 2001 Jan-Feb;18(1):37-45. doi: 10.1177/104345420101800105. J Pediatr Oncol Nurs. 2001. PMID: 11172408

8

Predictive factors for all-trans retinoic acid-related differentiation syndrome in patients with acute promyelocytic leukemia.

Leblebjian H, DeAngelo DJ, Skirvin JA, Stone RM, Wadleigh M, Werner L, Neuberg DS, Bartel S, McDonnell AM. Leblebjian H, et al. Among authors: bartel s. Leuk Res. 2013 Jul;37(7):747-51. doi: 10.1016/j.leukres.2013.04.011. Epub 2013 May 1. Leuk Res. 2013. PMID: 23643326

9

Creating a fair and just culture: one institution's pat toward organizational change.

Connor M, Duncombe D, Barclay E, Bartel S, Borden C, Gross E, Miller C, Ponte PR. Connor M, et al. Among authors: bartel s. Jt Comm J Qual Patient Saf. 2007 Oct;33(10):617-24. doi: 10.1016/s1553-7250(07)33071-7. Jt Comm J Qual Patient Saf. 2007. PMID: 18030864

10

Safe practices and financial considerations in using oral chemotherapeutic agents.

Bartel SB. Bartel SB. Am J Health Syst Pharm. 2007 May 1;64(9 Suppl 5):S8-S14. doi: 10.2146/ajhp070036. Am J Health Syst Pharm. 2007. PMID: 17468158 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

217 results

Search Page

Filters